The effect of cicloxolone sodium (CCX) on the replication of vesicular stomatitis virus (VSV) was investigated. The drug was active during all stages of the virus replication cycle, indicating that it does not operate by the specific inhibition of any single essential virus gene product. The drug reduced the number of VSV particles assembled and released by 100- to 1000-fold. Infectious virus yield was reduced 1000- to 10000-fold, giving a 10-fold or greater increase in the particle/p.f.u. ratio. The reduced number of virus particles produced in the presence of CCX results from two superimposed effects: suppression of VSV secondary transcription and viral protein synthesis, and perturbation of virion assembly. The inhibition of VSV assembly is due to impairment of a Golgi apparatus function related to transport of VSV glycoprotein G to the cell surface, and is characterized by accumulation of viral G and M proteins within the cell. Incubation of VSV-infected cells in the presence of two glycosylation inhibitors, tunicamycin and monensin, similarly leads to intracellular accumulation of G and M proteins, suggesting a common mechanism of action affecting VSV virion assembly. The differential effect of CCX concentration on intracellular levels of the L, N and NS proteins was analysed. CCX also possesses a virucidal effect on mature infectious VSV particles in suspension, 300 µm reducing the VSV titre about 10-fold in 24 h at 4 °C or 37 °C. The mode of antiviral activity against VSV is compared with that against herpes simplex virus.
BossN. F.,
MooreD. J.,
MollenhaverH. H.1984; Monsenin-induced swelling of the Golgi apparatus cisternae mediated by a proton gradient. European Journal of Cell Biology 34:1–8
CsonkaG. W.,
TyrrellD. A. J.1984; Treatment of herpes genitalitis with carbenoxolone and cicloxolone creams: a double-blind placebo-controlled clinical trial. British Journal of Venereal Diseases 60:178–181
DarganD. J.,
Subak-SharpeJ. H.1985; The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. I. Effect on cell growth, virus particles and virus replication. Journal of General Virology 66:1771–1784
DarganD. J.,
Subak-SharpeJ. H.1986a; The effect of triterpenoid compounds on uninfected and herpes simplex virus–infected cells in culture. II. DNA and protein synthesis, polypeptide processing and transport. Journal of General Virology 67:1831–1850
DarganD. J.,
Subak-SharpeJ. H.1986b; The antiherpes activity of the triterpenoid compounds carbenoxolone sodium and cicloxo-lone sodium. Journal of Antimicrobial Chemotherapy 18 supplement W 185–200
DarganD. J.,
Subak-SharpeJ. H.1991; The difference in sensitivity to cicloxolone sodium between herpes simplex virus types 1 and 2 maps to the locations of genes UL22 (gH) and UL44 (gC). Journal of General Virology 72:377–384
DarganD. J.,
AitkenJ. D.,
Subak-SharpeJ. H.1988; The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. III. Ultrastructural study of virion maturation. Journal of General Virology 69:439–444
DarganD. J.,
GaltC. B.,
Subak-SharpeJ. H.1992; The effect of cicloxolone sodium on the replication in cultured cells of adenovirus type 5, reovirus type 3, poliovirus type 1, two bunyaviruses and Semliki Forest virus. Journal of General Virology 73:407–411
EvansD.,
PringleC. R.,
SzilagyiJ. F.1979; Temperaturesensitive mutants of complementation group E of vesicular stomatitis virus. New Jersey serotype possesses altered NS polypeptides. Journal of Virology 31:325–333
FreemanG. J.,
RoseJ. K.,
ClintonG. M.,
HuangA. S.1977; RNA synthesis of vesicular stomatitis virus. VII. Complete separation of the mRNAs of vesicular stomatitis virus. Journal of Virology 21:1094–1104
GaltC.,
DarganD. J.,
Subak-SharpeJ. H.1990; In vitro studies of the antiviral range of cicloxolone sodium and identification of cell lines tolerant to the drug. Antiviral Chemistry and Chemotherapy 1:115–123
JohnsonP. C.,
SchlesingerM. J.1980; Vesicular stomatitis virus and Sindbis virus glycoprotein transport to the cell surface is inhibited by ionophores. Virology 103:407–424
JohnsonP. A.,
EverettR. D.1986; The control of herpes simplex virus type 1 late gene transcription: a ‘TATA-box’/cap site region is sufficient for fully efficient activity. Nucleic Acids Research 14:8247–8264
MarsdenH. S.,
CrombieI. K.,
Subak-SharpeJ. H.1976; Control of protein synthesis in herpesvirus-infected cells: analysis of the polypeptides induced by wild-type and sixteen temperature-sensitive mutants of HSV-1 strain 17. Journal of General Virology 31:347–372
MoyerS. A.,
BanerjeeA. K.1975; Messenger RNA species synthesised in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell 4:37–43
MoyerS. A.,
GrubmanM. J.,
EhrenfeldE.,
BanerjeeA. K.1975; Studies on the in vivo and in vitro messenger RNA species of vesicular stomatitis virus. Virology 67:463–473
MukherjeeP. K.,
SimpsonR. W.1987; Transcriptionally defective nucleocapsids of vesicular stomatitis virus from cells treated with indomethacin. Virology 156:25–31
PatersonR. G.1983Studies on the RNA and protein species synthesized in cells infected with ts mutants of VSV New Jersey Ph.D. thesis University of Glasgow:
RhodesD. P.,
AbrahamS. A.,
ColonnoR. J.,
JelnickW.,
BanerjeeA. K.1977; Characterization of vesicular stomatitis virus mRNA species synthesized in vitro. Journal of Virology 21:1205–1112
RobertsN. B.,
TaylorW. H.1980; The actions of carbenoxolone on enzymes and their relation to its therapeutic effect. Scandinavian Journal of Gastroenterology 15: supplement 6511–16
SymonsA. M.,
ParkeD. V.1980; The effects of carbenoxolone on the stability of cellular membranes. Scandinavian Journal of Gastroenterology 15: supplement 653–10
SzilágyiJ. F.,
CunninghamC.1991; Identification and characterization of a novel non-infectious herpes simplex virus-related particle. Journal of General Virology 72:661–668
VillarrealL. P.,
BreindlM.,
HollandJ. J.1976; Determination of molar ratios of vesicular stomatitis virus-induced RNA species in BHK-21 cells. Biochemistry 15:1663–1667